# Survival of Patients With Acute Heart Failure in Need of Intravenous Inotropic Support: a Multicentre, Parallel-Group, Randomised, Double-Blind, Double-Dummy Study of Levosimendan Versus Dobutamine in Patients With Acute Heart Failure.

> **NCT00348504** · PHASE3 · COMPLETED · sponsor: **Abbott** · enrollment: 1300 (—)

## Conditions studied

- Acute Heart Failure

## Interventions

- **DRUG:** levosimendan
- **DRUG:** dobutamine

## Key facts

- **NCT ID:** NCT00348504
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-03
- **Primary completion:** —
- **Final completion:** 2005-06
- **Target enrollment:** 1300 (—)
- **Last updated:** 2007-11-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00348504

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00348504, "Survival of Patients With Acute Heart Failure in Need of Intravenous Inotropic Support: a Multicentre, Parallel-Group, Randomised, Double-Blind, Double-Dummy Study of Levosimendan Versus Dobutamine in Patients With Acute Heart Failure.". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00348504. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*